U.S. Equestrian Athlete, Dutta, Accepts Public Warning for Anti-Doping Rule Violation
19 July 2016 – USADA announced today that Susan Dutta, of Wellington, Florida, an athlete in equestrian sport, has tested positive for a prohibited substance and accepted a public warning for her violation.
Dutta, 47, tested positive for the prohibited substance methylprednisolone as a result of an in-competition urine sample she provided on March 19, 2016, at the Global Dressage Festival 10 in Wellington, Florida. Methylprednisolone is a glucocorticosteroid prohibited in-competition by specific routes of administration under the United States Anti-Doping Agency ("USADA") Protocol for Olympic and Paralympic Movement Testing (the "Protocol"), the United States Olympic Committee ("USOC") National Anti-Doping Policies ("USOC NADP") and the International Equestrian Federation ("FEI") Anti-Doping Rules, all of which have adopted the World Anti-Doping Code ("Code") and the World Anti-Doping Agency Prohibited List.
After a thorough review of the case, including Dutta’s medical records, USADA has accepted her explanation that the methylprednisolone was used to treat an emergency condition, not being used in an effort to enhance her performance, and that she was taking the prescribed medication out-of-competition in a therapeutic dose under the care of a qualified physician, however without a valid TUE.
In addition to accepting a public warning, Dutta has been disqualified from all competitive results obtained on March 19, 2016, the date her positive sample was collected, including forfeiture of any medals, points and prizes.
In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
- Tags: Anti-Doping | Equestrian | Global DRO | International Equestrian Federation (FEI) | Olympic | Paralympic | United States of America (USA) | United States Olympic Committee (USOC) | US Anti-Doping Agency (USADA) | World Anti-Doping Agency (WADA) | World Anti-Doping Code (WADC)
- FINA Partners with 15 National Anti-Doping Organizations on Collaborative Testing Initiative for Rio
- U.S. Gymnastics Athlete, Shaldybin, Accepts Finding of No Fault for Anti-Doping Rule Violation
- U.S. Taekwondo athlete, Howe II, accepts sanction for anti-doping rule violation
- The UCI and USADA establish partnership for collaborative testing and results management efforts